Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ECG Nutrition and Supplements from Tessenderlo-Ham, company number BE0880624792, closed financial year 2025 with a result of € 2 million after tax. For that financial year ECG Nutrition and Supplements recorded revenue of € 10.6 million and equity of € 63.7 million. Compared with financial year 2024, the result moved from € 3 million to € 2 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 63.7 million
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2 million
▼ 33% vs 2024
Profit after tax over the fiscal year.
€ 484,976
▲ 42% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 5.9 million.
People and assets in 2025
12.5
▲ 3.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.3 million
▲ 71% vs 2024
€ 101,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 57,784
▼ 2% vs 2024
Of which on lease € 10,369.
Debts at end 2025
€ 18.3 million
▼ 5% vs 2024
€ 10,032 is repaid this year. At this pace the long-term loan is gone in ≈ 1823 years.
€ 3.4 million
▲ € 2.8 million vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 142 days on average.
€ 175,834
▲ 117% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 4,347,617 | € 6,057,297 | € 10,556,695 | ▲ 74% |
| Gross margin | € 377,392 | - | - | - | |
| Profit after taxes | € -211,738 | € 291,394 | € 3,002,325 | € 2,012,153 | ▼ 33% |
| Equity | € 20,834,725 | € 54,364,796 | € 58,717,121 | € 63,715,525 | ▲ 9% |
| Total debts | € 13,230,964 | € 16,510,881 | € 20,097,132 | € 22,167,206 | ▲ 10% |
| Cash | € 381,937 | € 241,914 | € 341,299 | € 484,976 | ▲ 42% |
| Retained profit | € 591,077 | € 882,471 | € 3,884,796 | € 5,896,949 | ▲ 52% |
| Bank debt | € 12,906,307 | € 13,878,371 | € 19,270,756 | € 18,287,062 | ▼ 5% |
| Balance sheet total | € 34,065,690 | € 70,875,677 | € 78,814,253 | € 85,882,731 | ▲ 9% |
| Employees (FTE) | 2.2 | 4 | 9 | 12.5 | ▲ 3.5 |
Key figures of ECG Nutrition and Supplements, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ECG Nutrition and Supplements?
What happened at ECG Nutrition and Supplements in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2 million (▼ 33% vs 2024). Source: NBB ↗
- T&K Partners BV became a director. NBB
- KAFINCO BV became a director. NBB
- Laurence Eugene Masterson stepped down as director. NBB
- Shatal BV stepped down as director. NBB
- Robertus Falk stepped down as director. NBB
- Equine Care Group NV stepped down as director. NBB
- Laurence Eugene Masterson became a director. NBB
In short
From € 211,738 loss in 2022 to € 2 million profit in 2025.
Paid € 4,299 in corporate taxes since 2022.
Best year ever: 2024, with € 3 million profit.
On average € 171,500 of value added per employee in 2022.
A new publication or filing at ECG Nutrition and Supplements? We notify you, reason included.
Follow ECG Nutrition and SupplementsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of EQUINE CARE GROUP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ECG Nutrition and SupplementsBehind ECG Nutrition and Supplements are T&K Partners BV and KAFINCO BV. The shares are held by EQUINE CARE GROUP (73.4%). It owns 100% of ROOSE, 100% of Sartilly Industries, 100% of ECG N&S Italy S.R.L., 100% of Pierre Matile, 100% of ECG N&S Ireland Limited and 100% of Navalis nutraceuticals itself.
Directors
According to the 2025 annual accounts
Director · represented by Tom Mariën
Also active at: SHATAL, ECG Clinics, ECG Labs, ECG Medical Care, EQUITOM
since 2025
Director · represented by Julie Santens
Also active at: DESOTEC, ROOSE, D.E.S.O.T.E.C. INTERNATIONAL, Zoolyx, David Bidco, ECG Labs, ECG Medical Care, ECG Ambulatory Care
since 2025
Laurence Eugene Masterson
Director
since 2023 · until 2025
Director · represented by Tom Mariën
Also active at: ROOSE, Dierenartsenpraktijk Hendrikx - Deuss, WESTPAILLE, ECG Clinics, Zoolyx, EQUINE CARE GROUP, EQUITOM LIEGE, REVERDY BENELUX +4 more
since 2010 · until 2025
Robertus Falk
Director
since 2023 · until 2025
Director · represented by Jonathan Mommer
since 2023 · until 2025
Shareholders
73.4%
Participations
100%
Sartilly Industries
100%
ECG N&S Italy S.R.L.
100%
Pierre Matile
100%
ECG N&S Ireland Limited
100%
Navalis nutraceuticals
100%
Feral Horse Care BV
100%
Establishments
Establishment units
Physical locations of this company
Truibroek 94 box 10
3945 Tessenderlo-Ham
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →BELKLIMA
€ -3,574 gross margin · 2025
HF PROJECTS
€ 267,493 gross margin · 2025
HDKL
€ 655,581 gross margin · 2025
LINOU
€ 58,508 gross margin · 2024
Vereniging van mede-eigenaars van het N73 KMO-PARK
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0880.624.792
- VAT number
- BE 0880.624.792
- Registered office
- Truibroek 94 bus 10, 3945 Tessenderlo-Ham
- Names & denominations
- ECG Nutrition and Supplements
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 April 2006
- Peppol
- Active · Active since 13 Jan 2026
- Activities · NACE
Groothandel in parfumerieën en cosmetica
Groothandel in andere voedingsmiddelen, neg
Overige gespecialiseerde groothandel in voedingswaren
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen
Handelsbemiddeling in voedings- en genotmiddelen